Dynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity

[1]  O. Gaye,et al.  Sero-epidemiological evaluation of Plasmodium falciparum malaria in Senegal , 2015, Malaria Journal.

[2]  K. Marsh,et al.  Plasmodium falciparum Malaria in Children Aged 0-2 Years: The Role of Foetal Haemoglobin and Maternal Antibodies to Two Asexual Malaria Vaccine Candidates (MSP3 and GLURP) , 2014, PloS one.

[3]  J. Rayner,et al.  New antigens for a multicomponent blood-stage malaria vaccine , 2014, Science Translational Medicine.

[4]  K. Marsh,et al.  Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria , 2014, BMC Medicine.

[5]  C. Rogier,et al.  The rise and fall of malaria in a West African rural community, Dielmo, Senegal, from 1990 to 2012: a 22 year longitudinal study. , 2014, The Lancet. Infectious diseases.

[6]  S. Sirima,et al.  Malaria Incidence in Children in South-West Burkina Faso: Comparison of Active and Passive Case Detection Methods , 2014, PloS one.

[7]  K. Marsh,et al.  Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  B. Lowe,et al.  A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria☆ , 2013, Vaccine.

[9]  J. Keefer,et al.  A Role for Fetal Hemoglobin and Maternal Immune IgG in Infant Resistance to Plasmodium falciparum Malaria , 2011, PloS one.

[10]  D. Conway,et al.  Allelic Diversity and Naturally Acquired Allele-Specific Antibody Responses to Plasmodium falciparum Apical Membrane Antigen 1 in Kenya , 2010, Infection and Immunity.

[11]  Jack S. Richards,et al.  The Relationship between Anti-merozoite Antibodies and Incidence of Plasmodium falciparum Malaria: A Systematic Review and Meta-analysis , 2010, PLoS medicine.

[12]  K. Marsh,et al.  What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity , 2009, Malaria Journal.

[13]  R. Chilengi,et al.  Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children , 2008, Malaria Journal.

[14]  D. Conway,et al.  Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria , 2008, Infection and Immunity.

[15]  S. Cousens,et al.  Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria? , 2008, Tropical medicine & international health : TM & IH.

[16]  C. Long,et al.  Fetal Immune Responses to Plasmodium falciparum Antigens in a Malaria-Endemic Region of Cameroon1 , 2007, The Journal of Immunology.

[17]  S. Issifou,et al.  Malaria and asymptomatic parasitaemia in Gabonese infants under the age of 3 months. , 2005, Acta tropica.

[18]  V. Schramm,et al.  Effect of dietary p-aminobenzoic acid on murine Plasmodium yoelii infection. , 2003, The Journal of infectious diseases.

[19]  R. Anders,et al.  Lack of Association between Maternal Antibody and Protection of African Infants from Malaria Infection , 2000, Infection and Immunity.

[20]  Tanner,et al.  Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: relationships with clinical malaria and with entomological inoculation rates , 1999, Parasite immunology.

[21]  S. Bennett,et al.  Clinical case definitions for malaria: clinical malaria associated with very low parasite densities in African infants. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[22]  S. Bennett,et al.  High incidence of asymptomatic malara infections in a birth cohort of children less than one year of age in Ghana, detected by multicopy gene polymerase chain reaction. , 1998, The American journal of tropical medicine and hygiene.

[23]  R. Snow,et al.  Risk of severe malaria among African infants: direct evidence of clinical protection during early infancy. , 1998, The Journal of infectious diseases.

[24]  P. Perlmann,et al.  Lack of association between levels of transplacentally acquired Plasmodium falciparum-specific antibodies and age of onset of clinical malaria in infants in a malaria endemic area of Nigeria. , 1996, Acta tropica.

[25]  E. Riley,et al.  Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass , 1995, Infection and immunity.

[26]  A. Holder,et al.  Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. , 1994, Molecular and biochemical parasitology.

[27]  A. Sabchareon,et al.  Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. , 1991, The American journal of tropical medicine and hygiene.

[28]  P. Hindocha,et al.  The placental transfer of IgG subclasses in human pregnancy. , 1980, Clinical and experimental immunology.

[29]  I. McGregor,et al.  Treatment of East African P. falciparum malaria with West African human γ-globulin , 1963 .

[30]  H. Gilles,et al.  ADULT AND CORD-BLOOD GAMMA-GLOBULIN AND IMMUNITY TO MALARIA IN NIGERIANS , 1962 .

[31]  I. McGregor,et al.  Gamma-Globulin and Acquired Immunity to Human Malaria , 1961, Nature.

[32]  R. C. Muirhead-Thomson.  Distribution of Anopheline Mosquito Bites Among Different Age Groups , 1951 .

[33]  R. C. Muirhead-Thomson.  The distribution of anopheline mosquito bites among different age groups; a new factor in malaria epidemiology. , 1951, British medical journal.

[34]  P. Kremsner,et al.  Reduced cord blood immune effector-cell responsiveness mediated by CD4+ cells induced in utero as a consequence of placental Plasmodium falciparum infection. , 2006, The Journal of infectious diseases.

[35]  O. Branch,et al.  Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project. , 2002, The American journal of tropical medicine and hygiene.

[36]  P. Carnevale,et al.  [The aggressiveness of Anopheles gambiae A in relation to the age and sex of the human subjects]. , 1978, Bulletin of the World Health Organization.

[37]  P. Carnevale,et al.  Etude de l'agressivité d' Anopheles gambiae A en fonction de l'âge et du sexe des appâts humains , 1978 .